106 related articles for article (PubMed ID: 27672007)
1. A comparative study of renal care in Brazil and Mexico: hemodialysis treatment from the perspective of ESRD sufferers.
Mercado-Martinez FJ; da Silva DG; Correa-Mauricio ME
Nurs Inq; 2017 Apr; 24(2):. PubMed ID: 27672007
[TBL] [Abstract][Full Text] [Related]
2. [Living in hemodialysis without social insurance: The voices of renal sick people and their families].
Mercado-Martínez FJ; Correa-Mauricio ME
Salud Publica Mex; 2015; 57(2):155-60. PubMed ID: 26235776
[TBL] [Abstract][Full Text] [Related]
3. Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach.
Agudelo-Botero M; González-Robledo MC; Reyes-Morales H; Giraldo-Rodríguez L; Rojas-Russell M; Mino-León D; Ocampo-Morales DI; Valdez-Ortiz R
Int J Equity Health; 2020 Jun; 19(1):90. PubMed ID: 32513177
[TBL] [Abstract][Full Text] [Related]
4. Disparities in renal care in Jalisco, Mexico.
Garcia-Garcia G; Renoirte-Lopez K; Marquez-Magaña I
Semin Nephrol; 2010 Jan; 30(1):3-7. PubMed ID: 20116641
[TBL] [Abstract][Full Text] [Related]
5. Overview of hemodialysis treatment funded by the Brazilian Unified Health System--An economic perspective.
Menezes FG; Barreto DV; Abreu RM; Roveda F; Pecoits Filho RF
J Bras Nefrol; 2015; 37(3):367-78. PubMed ID: 26398647
[TBL] [Abstract][Full Text] [Related]
6. Meeting Treatment Goals in Patients on Extramural Dialysis in Health Social Security in Mexico.
Muñoz-Menjivar C; Reyes-Sánchez I; Aguilar-Martínez C; Rodríguez-Rodríguez A; Mendoza-Gómez JL; Guerrero-Soto J; Lizardi-Gómez LF; Venegas-Vera AV; Hernández-Rivera JCH; Ramos-Sánchez A; Paniagua R
Blood Purif; 2021; 50(1):93-101. PubMed ID: 32604095
[TBL] [Abstract][Full Text] [Related]
7. End-stage renal failure and national resources: the Brazilian experience.
Zatz R; Romão JE
Ren Fail; 2006; 28(8):627-9. PubMed ID: 17162419
[TBL] [Abstract][Full Text] [Related]
8. The viability of hemodialysis as a treatment option for renal failure in a developing economy.
Arije A; Kadiri S; Akinkugbe OO
Afr J Med Med Sci; 2000; 29(3-4):311-4. PubMed ID: 11714013
[TBL] [Abstract][Full Text] [Related]
9. Cost calculations during "dire straits": a cost-of-illness analysis of regular hemodialysis for end-stage renal disease in Greece.
Naoum P; Topkaroglou I; Kitsonis D; Skroumpelos A; Athanasakis K; Iatrou C; Boletis J; Kyriopoulos J
Int J Artif Organs; 2016 Feb; 39(2):87-9. PubMed ID: 26953901
[TBL] [Abstract][Full Text] [Related]
10. Coping with kidney disease - qualitative findings from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study.
Subramanian L; Quinn M; Zhao J; Lachance L; Zee J; Tentori F
BMC Nephrol; 2017 Apr; 18(1):119. PubMed ID: 28372582
[TBL] [Abstract][Full Text] [Related]
11. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
12. The Latin American Dialysis and Transplantation Registry (RLDT) annual report 2004.
Cusumano A; Garcia GG; Di Gioia C; Hermida O; Lavorato C;
Ethn Dis; 2006; 16(2 Suppl 2):S2-10-3. PubMed ID: 16774002
[TBL] [Abstract][Full Text] [Related]
13. Cost comparison of kidney transplant versus dialysis in Brazil.
Silva SB; Caulliraux HM; Araújo CA; Rocha E
Cad Saude Publica; 2016 Jun; 32(6):. PubMed ID: 27383457
[TBL] [Abstract][Full Text] [Related]
14. [Current status of alternative therapies renal function at the Instituto Mexicano del Seguro Social].
Méndez-Durán A; Ignorosa-Luna MH; Pérez-Aguilar G; Rivera-Rodríguez FJ; González-Izquierdo JJ; Dávila-Torres J
Rev Med Inst Mex Seguro Soc; 2016; 54(5):588-93. PubMed ID: 27428340
[TBL] [Abstract][Full Text] [Related]
15. Gaining efficiencies: resources and demand for dialysis around the globe.
Neil N; Walker DR; Sesso R; Blackburn JC; Tschosik EA; Sciaraffia V; García-Contreras F; Capsa D; Bhattacharyya SK
Value Health; 2009; 12(1):73-9. PubMed ID: 18680485
[TBL] [Abstract][Full Text] [Related]
16. The Lived Experience of Patients Receiving Hemodialysis Treatment for End-Stage Renal Disease: A Qualitative Study.
Chiaranai C
J Nurs Res; 2016 Jun; 24(2):101-8. PubMed ID: 26275156
[TBL] [Abstract][Full Text] [Related]
17. End-stage renal disease and its treatment in Latin America in the twenty-first century.
Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
[TBL] [Abstract][Full Text] [Related]
19. Substitute treatment and replacement in chronic kidney disease: peritoneal dialysis, hemodialysis and transplant.
Treviño-Becerra A
Cir Cir; 2009; 77(5):411-5. PubMed ID: 19944033
[TBL] [Abstract][Full Text] [Related]
20. Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil.
Sesso R; da Silva CB; Kowalski SC; Manfredi SR; Canziani ME; Draibe SA; Elgazzar HA; Ferraz MB
Int J Technol Assess Health Care; 2007; 23(1):126-30. PubMed ID: 17234026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
